title: Diagnosis and treatment of prostate cancer in renal-transplant recipients.
abstract: BACKGROUND
  The incidence and treatment of prostate cancer in male renal-transplant patients has not been extensively evaluated. With the aging of the renal-transplant population, the diagnosis and management of prostate cancer in these patients needs further evaluation.
  
  
  METHODS
  In this study, we conducted a retrospective review of data from 498 male renal-transplant patients to evaluate the prevalence, treatment, and outcome of prostate cancer in this population.
  
  
  RESULTS
  Of the 498 male renal-transplant patients, nine were diagnosed with prostate cancer. A prostate specific antigen (PSA) screening program was not utilized, and these patients were diagnosed based on a prostate digital rectal examination and/or elevated PSA. The median age at transplantation was 55 years, and the median age at the diagnosis of prostate cancer was 63.6 years. One patient was treated with androgen ablation alone, four patients were with radiation alone, and four patients were treated with a combination of androgen ablation and external radiation. Twelve skin malignancies occurred in five of the patients with prostate cancer. Our patient population was preferentially treated with radiation therapy rather than radical prostatectomy. Seven of these treated patients are currently being followed and have good control of the disease. Two of the seven patients are on dialysis because of chronic allograft nephropathy. One patient was lost to follow-up, and one died with extensive metastasis, paraplegia, and renal failure.
  
  
  CONCLUSIONS
  The incidence of diagnosed prostate cancer in patients with renal transplant will increase because of systematic PSA screening. The recommended current treatment modality depends on the Gleason grade, stage, PSA levels, and associated comorbid conditions. A combination of radiation treatment with androgen ablation provides good control of the disease while preserving renal function.
authors: Division of Urology, Department of Surgery, Faculty of Medicine, King Saud University, PO Box 36175, Riyadh 1149, Saudi Arabia. surgon@hotmail.com
authors: Saleh
authors: S
authors: Binsaleh
references: Transplantation. 2000 Jun 15;69(11):2461-2
references: 10868663
references: Urology. 2006 Sep;68(3):672.e5-7
references: 16979728
references: Urology. 1999 Apr;53(4):822-4
references: 10197867
references: J Heart Lung Transplant. 2005 Aug;24(8):995-7
references: 16102432
references: Transplantation. 1990 Mar;49(3):506-9
references: 2316011
references: Transplantation. 2002 May 27;73(10):1565-72
references: 12042641
references: J Urol. 2004 Aug;172(2):435-7
references: 15247698
references: Arch Dermatol. 1986 Nov;122(11):1288-93
references: 3535683
references: Transplantation. 2003 Jan 27;75(2):237-9
references: 12548131
references: Int J Cancer. 1995 Jan 17;60(2):183-9
references: 7829213
references: BJU Int. 2005 Feb;95(3):319-22
references: 15679786
references: Transplant Proc. 1999 Feb-Mar;31(1-2):1263-5
references: 10083563
references: Drug Saf. 2000 Aug;23(2):101-13
references: 10945373
references: Transplant Proc. 2005 Jun;37(5):2089-92
references: 15964347
references: Transplantation. 2004 Nov 27;78(10):1496-500
references: 15599314
references: Urology. 1998 Sep;52(3):428-32
references: 9730455
references: Urology. 2008 Feb;71(2):205-8
references: 18308084
references: BJU Int. 2010 Mar;105(6):844-8
references: 19804426